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Conclusions: Our results clearly illustrate that not all brands of CS act
similarly: depending on their origin and purity some may be highly
efﬁcacious while others may even induce unwanted effects. Thus, the
use of pharmaceutical-grade CS is strongly recommended. Finally, this
study also indicates that proteomic analysis is a promising approach for
further anti-OA drugs screening.
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Purpose: This study exploited an explant culture model of articular
cartilage to examine the time course of protein release in the secretome
in response to pro-inﬂammatory cytokines and a non-steroidal anti-
inﬂammatory drug. Aggregating proteoglycans and smaller matrix
proteins such as cartilage oligomeric matrix protein (COMP), decorin
and biglycan are continuously released from this model but their high
abundance interferes with the dynamic range of gel-based separation and
detection techniques and downstream identiﬁcation of lower abundance
molecules. Our aim was to investigate the order and timing of protein
release and determine the optimal time point where the release of these
abundant molecules decreases sufﬁciently, allowing more in-depth high-
throughput analysis in subsequent studies.
Methods: Cartilage was obtained from animals euthanized for purposes
other than research. Explant cultures of equine articular cartilage were
established from metacarpophalangeal joints of 3 horses. Full depth
cartilage shavings were excised and washed with PBS (containing 10%
penicillin/streptomycin). Explant discs were prepared using a 3mm
biopsy punch and pre-incubated in serum-free DMEM supplemented
with 2% penicillin/streptomycin (15 discs per 3ml media) in a CO2
incubator for 24 hours at 37°C. Explants were incubated alone (control
media), or with recombinant IL-1b alone or in combination with TNF-a
(each at 10ng/ml), the non-steroidal anti-inﬂammatory drug carprofen
(Rimadyl, Pﬁzer Animal Health, 100mg/ml) or carprofen with IL-1b and
TNF-a combined (100mg/ml and 10ng/ml respectively). Supernatants
were removed every three days and replaced with fresh experimental
media at various time points (every 24 hours for 3 days, and every 3 days
thereafter, up to 27 days), to monitor the progression of protein release.
Proteins in the secretome were separated by SDS-PAGE and silver stained
before identiﬁcation using nanoLC-ESI-MS/MS analysis.
Fig. 1.
Results: Figure 1 illustrates the time course of protein release from
cartilage explants over a period of 27 days in culture. Table 1 summarizes
information about the proteins identiﬁed from silver-stained 1D-SDS-
PAGE gels. Proteins identiﬁed from SDS-PAGE gels included hyaluronan
and proteoglycan link protein 1, COMP and matrix metalloproteinase
3 (MMP-3), which are in agreement with previous studies from our
laboratory. Treatment with carprofen signiﬁcantly reduced the release
of IL-1b stimulated MMP-3 after 15 days in culture. Furthermore, the
release of abundant molecules decreased in all treatments after 15 days
in culture.
Table 1. Selected proteins identiﬁed from silver-stained 1D-SDS-PAGE
gels.
Protein Name Database Entry Mascot
score
Peptides
matched
Functional Role
Cartilage oligomeric matrix protein,
COMP (Equus caballus)
gi 126352424 463 12 Extracellular matrix
associated protein
involved in collagen
ﬁbril organisation
Matrix metalloproteinase 3, MMP-3
(Equus caballus)
MMP3_HORSE 513 10 Catabolic matrix
metalloproteinase,
involved in
extracellular matrix
degradation
Alpha-enolase (Homo sapiens) gi 2661039 116 3 Intracellular glycolytic
enzyme
Hyaluronan and proteoglycan link
protein 1 (Equus caballus)
HPLN1_HORSE 130 2 Provides the linkage
between hyaluronan
and proteoglycans
Conclusions: The data presented support the view that cartilage explants
continue to release proteins including COMP and MMP-3 in response
to IL-1b treatment for up to 27 days in culture. Future studies using
high-throughput proteomics may allow us to focus on lower abundance
proteins released at critical points during long-term culture experiments
with pro-inﬂammatory cytokines and anti-inﬂammatory drugs. This may
prove to be a useful strategy for identifying new biomarkers and studying
dynamic changes in the secretome of cartilage explants in response to
relevant pathophysiological stimuli.
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Purpose: Aging is the primary risk factor for osteoarthritis (OA), a joint
disease involving altered tissue metabolism and increased oxidative
stress. Oxidative stress is believed to contribute to OA progression
by activation of matrix degradation and inhibition of matrix repair.
A decrease in antioxidant protein expression may contribute to the
pro-oxidative state of articular cartilage; however, the cellular anti-
oxidant defense system is redundant making it difﬁcult to assess changes
in antioxidant function without a comprehensive analysis of multiple
antioxidant pathways. We utilized selected reaction monitoring tandem
mass spectrometry, a quantitative proteomics method, to determine the
effect of aging on changes in over 17 antioxidant proteins from rat knee
articular cartilage.
Methods: We studied adult (10 months, N =20) and aged (29 months,
N =19) male F344BN rats, which were purchased from NIH’s Aging
Rodent Colony. Left and right knee joints were sectioned and stained
for histological grading of cartilage OA pathology (N=8 per age). We
developed a proteomic database of target peptide sequences to identify
antioxidant protein expression. Cartilage (N=5 per age) was collected
from the femur and tibia of both knees and frozen at −80C before
analysis. For each sample, 20mg of protein was run into an SDS-PAGE gel
and digested with trypsin in the gel. The peptides were extracted from
the gel and analyzed by a LC-tandem MS system (ThermoScientiﬁc). The
mass spectrometer was operated in the selected reaction monitoring
mode. The parameters for each protein are based on the detection of the
peptides produced by the tryptic digestion.
Results: Aged rats showed signiﬁcantly more OA pathology compared to
adult rats. The average OA cartilage score of aged rats was 2-fold greater
than that for adults. OA scores were greater in the lateral compartment
compared to the medial compartment. Quantitative mass spectrometry
identiﬁed 17 antioxidant proteins that are associated with both the
mitochondria and cytosol (Table 1). The 5 highest expressed proteins in
adult rats were the same as in aged rats, which are Sod1, Gstp1, Akr1b1,
Prdx6 and Prdx2.
Conclusion: We have characterized the F344BN rat as an animal model
of aging associated knee OA. Quantitative proteomics using selected
reaction monitoring provides a novel way for us to proﬁle rat cartilage
antioxidant proteins in a single experiment. 17 antioxidant proteins are
detected in rat cartilage, with Sod, Prdx and Gst being most highly
expressed. These enzymes convert superoxide to hydrogen peroxide
and then hydrogen peroxide to water. These actions make this set of
